Analysts Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) Price Target at $42.86
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been given an average recommendation of “Buy” by the nine analysts that are covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been given an average recommendation of “Buy” by the nine analysts that are covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
